UK Markets open in 5 hrs 24 mins

MDxHealth SA (MXDHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.16000.0000 (0.00%)
At close: 01:35PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.1600
Open1.1600
BidN/A x N/A
AskN/A x N/A
Day's range1.1600 - 1.1600
52-week range1.0100 - 1.7800
Volume3,000
Avg. volume272
Market cap170.198M
Beta (5Y monthly)1.33
PE ratio (TTM)N/A
EPS (TTM)-0.3400
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    MDxHealth Shareholder Transparency Declarations

    NEWS RELEASE – REGULATED INFORMATION 22 November 2021, 11:00 p.m. CET MDxHealth Shareholder Transparency Declarations IRVINE, CA, and HERSTAL, BELGIUM – 22 November 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company" or "MDxHealth"), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 on the disclosure of important participations in issuers of which shares are admitted to trading on a regulated marke

  • Globe Newswire

    MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States

    NEWS RELEASE – REGULATED INFORMATION 15 November 2021, 11:00 p.m. CET MDxHealth Shareholder Transparency Declarations IRVINE, CA, and HERSTAL, BELGIUM – 15 November 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company" or "MDxHealth"), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 on the disclosure of important participations in issuers of which shares are admitted to trading on a regulated marke

  • Globe Newswire

    MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States

    NEWS RELEASE - REGULATED INFORMATIONINSIDE INFORMATION4 NOVEMBER 2021, 13:00 CET MDxHealth Announces Pricing of Initial Public Offering of ADSsin the United States IRVINE, CA, and HERSTAL, BELGIUM – November 4, 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), a commercial-stage precision diagnostics company, today announced the pricing of its initial public offering in the United States (the "Offering") of 3,750,000 American Depositary Shares (each represe